In the present study, homozygous mutations of the CLDN16 gene were detected in a 20-year-old female who was clinically diagnosed with hypomagnesemia, hypocalcemia, hypercalciuria, bilateral nephrocalcinosis, and CKD stage G4. This evidence concerns the gene CLDN16 and nephrocalcinosis.